Growth hormone (GH) secretion is pulsatile en all species studied to date. Growth hormone-releasing hormone (GHRH) appears to stimulate GH synthesis and release whereas somatostatin (SRIF) is involved in the inhibition of GH release. Present understanding of the stimulatory and inhibitory interactions between hypothalamic factors has primarily come from in vitro and animal studies. Likewise, the mechanisms of action of several pharmacological agents that are used to clinically assess GH reserve have only been studied in animal models or by inferential human studies. However, because of large interspecies variation in the control of GH secretion, the data obtained in animals may not be applicable to humans. We have recently begun in vivo human studies that are directed at investigating the role of GHRH in GH secretion, using as a tool, a specific antagonist to GHRH, GHRH-Ant. These studies have allowed us to definitively assign an important role to GHRH in the generation of spontaneous GH pulses in humans as well as to determine that the GH responses to L-dopa and arginine are GHRH dependent. We are now extending our preliminary investigations to explore the mechanisms responsible for GH deficiency in the elderly by determining the dose responses of GH to GHRH-Ant. We suggest that GH deficiency in aging is consequent upon GHRH deficiency. If this were the case, the dose-response curve of the GH suppression by GHRH-Ant should be shifted to the left in the elderly population, i.e. lower doses of antagonist would be needed to suppress plasma GH concentrations.

Project Start
1998-12-01
Project End
1999-11-30
Budget Start
1998-10-01
Budget End
1999-09-30
Support Year
39
Fiscal Year
1999
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Type
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Spengler, Erin K; Kleiner, David E; Fontana, Robert J (2017) Vemurafenib-induced granulomatous hepatitis. Hepatology 65:745-748
Heidemann, Lauren; Law, James; Fontana, Robert J (2017) A Text Searching Tool to Identify Patients with Idiosyncratic Drug-Induced Liver Injury. Dig Dis Sci 62:615-625
Robarge, Jason D; Desta, Zereunesay; Nguyen, Anne T et al. (2017) Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer. Breast Cancer Res Treat 161:453-461
Crane, Natania A; Jenkins, Lisanne M; Bhaumik, Runa et al. (2017) Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain 140:472-486
Hertz, Daniel L; Speth, Kelly A; Kidwell, Kelley M et al. (2017) Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast Cancer Res Treat 165:659-668
Hertz, D L; Kidwell, K M; Seewald, N J et al. (2017) Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. Pharmacogenomics J 17:521-527
Kadakia, Kunal C; Kidwell, Kelley M; Seewald, Nicholas J et al. (2017) Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast Cancer Res Treat 164:411-419
Law, Ian H; Alam, Osman; Bove, Edward L et al. (2016) Follow-Up of a Prospective Surgical Strategy to Prevent Intra-Atrial Reentrant Tachycardia After the Fontan Operation. Circ Arrhythm Electrophysiol 9:
Schrepf, Andrew; Harper, Daniel E; Harte, Steven E et al. (2016) Endogenous opioidergic dysregulation of pain in fibromyalgia: a PET and fMRI study. Pain 157:2217-2225
As-Sanie, Sawsan; Kim, Jieun; Schmidt-Wilcke, Tobias et al. (2016) Functional Connectivity is Associated With Altered Brain Chemistry in Women With Endometriosis-Associated Chronic Pelvic Pain. J Pain 17:1-13

Showing the most recent 10 out of 1380 publications